Op-Eds
Good Drugs, Bad Rap
These are turbulent times for the pharmaceutical industry and for its regulator, the FDA. Lately, both have focused increasingly on issues of safety.
Op-Eds
The Long REACH of the EU
The European Union's Council of Ministers is expected to vote soon on the proposed chemicals regulation called REACH, an acronym for Registration, Evaluation, and…
Op-Eds
The UN’s War Against Innovation
The leadership of the United Nations is truly the gang that can't shoot straight. Even if the recent incidents of corruption and profiteering—exemplified…
Op-Eds
Making Sense of Drug Safety
Have you ever tried to read the official FDA-approved labeling for a drug? It's tough going even for physicians who are trying to…
Op-Eds
Mad Science
I enjoy a spirited, well-argued political argument as much as anybody, but in “The Republican War on Science,” journalist Chris Mooney offers only a tiresome…
Op-Eds
Ignore Rumors; Teflon Proven to Be Safe
The uncanny ability of President Ronald Reagan to deflect public criticism won him the nickname “The Teflon President.” Ironically, now it is Teflon…